查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829887

2025年全球肿瘤消融设备市场报告

Tumor Ablation Therapy Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤消融设备市场快速扩张，市场规模从2024年的7.2亿美元成长至2025年的8.2亿美元，复合年增长率达14.2%。预测期内的成长归因于癌症发生率上升、技术进步、人口老化以及微创手术的普及。

预计未来几年肿瘤消融器械市场将快速成长，到2029年将达到14.2亿美元，复合年增长率为14.6%。预测期内的成长归因于个人化医疗、联合治疗、人工智慧和影像引导消融、远端医疗和远距会诊以及培训和教育。预测期内的主要趋势包括消融技术、影像引导、机器人和导航辅助、免疫肿瘤学整合、经皮消融以及影像引导消融的进步。

肿瘤消融器械是常用于治疗肾臟、肝臟和肺部肿瘤的微创工具。这些器械利用多种技术瞄准并摧毁癌细胞，同时不伤害周围的健康组织。

肿瘤消融设备的主要技术包括射频消融、微波消融、冷冻消融、不可逆电穿孔消融及相关方法。不可逆电穿孔 (IRE) 是肿瘤消融治疗中的一项创新技术，该技术将微秒至毫秒的电脉衝施加于不必要的组织，导致细胞膜不可逆通透化和细胞坏死。这些设备的治疗可以采用外科手术、腹腔镜介入或经皮形式，适用于治疗各种类型的癌症，包括肾臟癌、肝癌、乳癌、肺癌和摄护腺癌。肿瘤消融设备的最终用户包括医院、肿瘤诊所和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肿瘤消融设备市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的肿瘤消融设备细分市场、市场趋势和机会，以及您在肿瘤消融设备行业取得成功所需的数据。本肿瘤消融设备市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年14.6%的成长率预测，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，导致来自加拿大和比利时等关键地区的微波天线阵列和热监测感测器供应链中断，从而导致微创癌症治疗系统的供应减少。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

由于癌症发生率的上升，肿瘤消融设备市场正在成长。癌症是导致死亡的主要原因，约占全球六分之一的死亡人数。肿瘤消融是一种微创手术，广泛用于治疗各种类型的肿瘤，包括肺癌、肝癌、肾臟癌和骨癌。例如，美国非营利医疗组织美国癌症协会 ( 美国 Cancer Society Inc.) 估计，2023 年美国将新增约 1,958,310 例癌症病例，高于 2022 年的 1,918,030 例。这种治疗方法提供了一种有效的治疗选择，特别是对于对化疗或放射线治疗无反应的患者，从而支持了肿瘤消融设备市场的成长。

微创手术需求的不断增长预计将推动肿瘤消融器械市场的发展。微创手术需要使用专门的器械和技术来最大程度地减少切口，从而减少对患者身体的伤害。肿瘤消融器械在这些手术中发挥关键作用，能够有效地摧毁肿瘤，同时最大限度地减少对周围组织的伤害。例如，美国机器人产品製造商Intuitive Surgical Inc.在2023年1月报告称，2022年使用达文西手术系统进行的手术约有187.5万例，较2021年的约159.4万例增长了18%。因此，微创手术需求的不断增长预计将推动肿瘤消融器械市场的成长。

肿瘤消融设备市场的主要企业正专注于技术进步，例如简化操作流程、提高安全性、减少辐射暴露、缩短学习曲线以及改善患者预后。例如，2023年4月，台湾电子产品製造商仁宝电子宣布推出经皮，这是一款新型射频消融术 (RFA) 系统，专为经皮、术中软组织（尤其是无法切除的肝臟病变）的凝固和消融而设计。此系统利用电阻在目标组织中产生热能，从而消融病灶。该系统有望应用于治疗医疗设备，尤其是癌症治疗。

领先的公司正专注于开发微创治疗方法，以增强其市场竞争力。微创治疗在肿瘤切除方面非常有效，可以在实现精准治疗的同时最大限度地减少对周围组织的破坏。例如，美国弗朗西斯医疗公司（Francis Medical）是一家为前列腺癌、肾臟癌和膀胱癌提供微创治疗解决方案的公司，其微创水蒸气消融疗法Vanquish于2023年8月获得美国食品药物管理局（FDA）颁发的突破性设备认证。该认证旨在加快该设备的开发和监管评估，确保其能够快速应用于患者。 Vanquish系统利用无菌水的热能，透过简单的经尿道手术对癌组织进行精准治疗，从而最大限度地降低前列腺癌替代疗法相关的严重副作用风险。

2022年8月，总部位于加拿大的泌尿系统癌症治疗公司Imagin Medical以250万美元的价格从TROD Medical NV收购了用于前列腺癌的enCAGE线圈精准消融系统。此次收购巩固了Imagin Medical作为泌尿系统肿瘤治疗公司的地位，并扩大了其在前列腺癌领域的产品组合。 TROD Medical NV是一家总部位于比利时的医疗设备公司。

肿瘤消融设备市场的主要公司包括 Galil Medical Inc.、Misonix Inc.、HealthTronics Inc.、AngioDynamics Inc.、Boston Scientific Corporation、Medtronic PLC、EDAP TMS SA、NeuWave Medical Inc.、BVM Medical Limited、Erbe Elektromedizin GmbH、AtriCure Olympus Corporation过程. 、Stryker Corporation、Merit Medical Systems Inc.、Insightec Ltd.、 Terumo Corporation、Smith & Nephew PLC、Monteris Medical Corporation、IceCure Medical Ltd.、Profound Medical Inc.、Alpinion Medical Systems Co.Ltd.、Sonacare Medical、Hologic Inc.、Endocare Inc.、Integraia Corporation Corporation。

2024年，肿瘤消融设备市场最大的地区是北美。亚太地区是肿瘤消融设备市场的第二大地区。肿瘤消融设备市场报告涵盖以下地区：亚太地区、西欧、东欧、北美、南美、中东和非洲。

肿瘤消融设备市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。

肿瘤消融器械市场涵盖用于肿瘤切除治疗的射频消融术、微波消融、冷冻消融和不可逆电穿孔消融器械的销售。该市场中的商品价值为出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤消融设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球肿瘤消融设备市场：成长率分析
  • 全球肿瘤消融设备市场表现：规模与成长，2019-2024
  • 全球肿瘤消融设备市场预测：规模与成长，2024-2029年，2034年
  • 全球肿瘤消融设备：总目标市场（TAM）

第六章 市场细分

  • 全球肿瘤消融设备市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 射频消融
  • 微波消融
  • 冷冻疗法
  • 不可逆电穿孔消融
  • 其他技术
  • 全球肿瘤消融设备市场按治疗类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 外科手术
  • 腹腔镜
  • 经皮
  • 全球肿瘤消融设备市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 肾癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 其他用途
  • 全球肿瘤消融设备市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 肿瘤诊所
  • 其他最终用户
  • 全球肿瘤消融设备市场：射频消融术(RFA) 细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单极射频消融装置
  • 双极射频消融装置
  • 全球肿瘤消融设备市场：微波消融设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 高频微波设备
  • 低频微波设备
  • 全球肿瘤消融设备市场：依冷冻疗法细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 基于液态氮的装置
  • 基于氩气的设备
  • 全球肿瘤消融设备市场：不可逆电穿孔消融 (IRE) 细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 奈米刀消融系统
  • 高压脉衝发生器
  • 全球肿瘤消融设备市场：依技术（其他）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 雷射消熔装置
  • 超音波导引高强度聚焦超音波（HIFU）
  • 化学消融技术

第七章 区域和国家分析

  • 全球肿瘤消融设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤消融设备市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肿瘤消融设备市场：竞争格局
  • 肿瘤消融设备市场：公司简介
    • Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Medtronic plc
  • EDAP TMS SA
  • NeuWave Medical Inc.
  • BVM Medical Limited
  • Erbe Elektromedizin GmbH
  • AtriCure Inc.
  • Theraclion
  • INTIO Inc.
  • BIOTRONIK SE & Co. KG
  • Olympus Corporation
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Insightec Ltd.
  • Terumo Corporation
  • Smith & Nephew plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肿瘤消融设备市场：提供新机会的国家
  • 2029年肿瘤消融设备市场：细分市场带来新机会
  • 2029年肿瘤消融设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r32827u

Tumor ablation therapy devices are minimally invasive tools used to treat tumors, typically in the kidney, liver, and lung. These devices utilize different techniques to target and destroy cancerous cells while safeguarding the surrounding healthy tissue.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.72 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.

The forecast of 14.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microwave antenna arrays and thermal monitoring sensors, sourced from key regions such as Canada and Belgium, could lead to reduced availability of minimally invasive cancer treatment systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

The rising demand for minimally invasive procedures is expected to propel the tumor ablation therapy devices market. Minimally invasive procedures involve specialized instruments and technology to minimize incisions, leading to less disruption to the patient's body. Tumor ablation therapy devices play a crucial role in these procedures by effectively destroying tumors while minimizing damage to surrounding tissues. For instance, in January 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, marking an 18% increase from the roughly 1,594,000 procedures conducted in 2021. Therefore, the growing demand for minimally invasive procedures is expected to drive the tumor ablation therapy devices market's growth.

Major companies in the tumor ablation therapy devices market are focusing on technological advancements to improve procedure efficiency, safety, reduce radiation exposure, shorten learning curves, and enhance patient outcomes. For instance, Compal Electronics, a Taiwan-based electronics manufacturing company, introduced AblatePal in April 2023, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, particularly non-resectable liver lesions. It employs electrical resistance to generate heat energy in the targeted tissue, resulting in its eradication. This system has applications in therapeutic medical devices, especially for cancer treatment.

Major companies are committed to developing minimally invasive therapies to gain a competitive edge in the market. Minimally invasive therapy is highly effective for tumor ablation, providing precise treatment with minimal disruption to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation aims to expedite the device's development and regulatory evaluation, potentially ensuring quicker patient access. The Vanquish system employs sterile water's thermal energy for precise cancer tissue treatment through a straightforward transurethral procedure, minimizing the risk of severe side effects associated with alternative prostate cancer therapies.

In August 2022, Imagin Medical, a Canada-based urologic oncology company, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from TROD Medical NV for $2.5 million. This acquisition strengthens Imagin's position as a urologic oncology company and broadens its portfolio in the field of prostate cancer. TROD Medical NV is a Belgium-based medical device company.

Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic PLC, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew PLC, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor ablation therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Ablation Therapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation therapy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
  • 2) By Treatment: Surgical; Laparoscopic; Percutaneous
  • 3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
  • 4) By End User: Hospitals; Oncology Clinics; Other End Users
  • Subsegments:
  • 1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices; Bipolar RFA Devices
  • 2) By Microwave Ablation: High-frequency Microwave Devices; Low-frequency Microwave Devices
  • 3) By Cryoablation: Liquid Nitrogen-based Devices; Argon Gas-based Devices
  • 4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems; High-voltage Pulse Generators
  • 5) By Other Technologies: Laser Ablation Devices; Ultrasound-guided High-intensity Focused Ultrasound (HIFU); Chemical Ablation Techniques
  • Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation; Medtronic plc; EDAP TMS S.A.; NeuWave Medical Inc.; BVM Medical Limited; Erbe Elektromedizin GmbH; AtriCure Inc.; Theraclion; INTIO Inc.; BIOTRONIK SE & Co. KG; Olympus Corporation; Stryker Corporation; Merit Medical Systems Inc.; Insightec Ltd.; Terumo Corporation; Smith & Nephew plc; Monteris Medical Corporation; IceCure Medical Ltd.; Profound Medical Inc.; Alpinion Medical Systems Co. Ltd.; Sonacare Medical; Hologic Inc.; Endocare Inc.; Integra LifeSciences Corporation; Bovie Medical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Trends And Strategies

4. Tumor Ablation Therapy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Ablation Therapy Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Ablation Therapy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Ablation Therapy Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Ablation Therapy Devices Total Addressable Market (TAM)

6. Tumor Ablation Therapy Devices Market Segmentation

  • 6.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • Other Technologies
  • 6.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical
  • Laparoscopic
  • Percutaneous
  • 6.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Oncology Clinics
  • Other End Users
  • 6.5. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Radiofrequency Ablation (RFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monopolar RFA Devices
  • Bipolar RFA Devices
  • 6.6. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Microwave Ablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-frequency Microwave Devices
  • Low-frequency Microwave Devices
  • 6.7. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Cryoablation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen-based Devices
  • Argon Gas-based Devices
  • 6.8. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Irreversible Electroporation Ablation (IRE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NanoKnife Ablation Systems
  • High-voltage Pulse Generators
  • 6.9. Global Tumor Ablation Therapy Devices Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Ablation Devices
  • Ultrasound-guided High-intensity Focused Ultrasound (HIFU)
  • Chemical Ablation Techniques

7. Tumor Ablation Therapy Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Ablation Therapy Devices Market

  • 8.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Ablation Therapy Devices Market

  • 9.1. China Tumor Ablation Therapy Devices Market Overview
  • 9.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Ablation Therapy Devices Market

  • 10.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Ablation Therapy Devices Market

  • 11.1. Japan Tumor Ablation Therapy Devices Market Overview
  • 11.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Ablation Therapy Devices Market

  • 12.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Ablation Therapy Devices Market

  • 13.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Ablation Therapy Devices Market

  • 14.1. South Korea Tumor Ablation Therapy Devices Market Overview
  • 14.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Ablation Therapy Devices Market

  • 15.1. Western Europe Tumor Ablation Therapy Devices Market Overview
  • 15.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Ablation Therapy Devices Market

  • 16.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Ablation Therapy Devices Market

  • 17.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Ablation Therapy Devices Market

  • 18.1. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Ablation Therapy Devices Market

  • 19.1. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Ablation Therapy Devices Market

  • 20.1. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Ablation Therapy Devices Market

  • 21.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
  • 21.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Ablation Therapy Devices Market

  • 22.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Ablation Therapy Devices Market

  • 23.1. North America Tumor Ablation Therapy Devices Market Overview
  • 23.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Ablation Therapy Devices Market

  • 24.1. USA Tumor Ablation Therapy Devices Market Overview
  • 24.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Ablation Therapy Devices Market

  • 25.1. Canada Tumor Ablation Therapy Devices Market Overview
  • 25.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Ablation Therapy Devices Market

  • 26.1. South America Tumor Ablation Therapy Devices Market Overview
  • 26.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Ablation Therapy Devices Market

  • 27.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Ablation Therapy Devices Market

  • 28.1. Middle East Tumor Ablation Therapy Devices Market Overview
  • 28.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Ablation Therapy Devices Market

  • 29.1. Africa Tumor Ablation Therapy Devices Market Overview
  • 29.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Ablation Therapy Devices Market Competitive Landscape
  • 30.2. Tumor Ablation Therapy Devices Market Company Profiles
    • 30.2.1. Galil Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Misonix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HealthTronics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Ablation Therapy Devices Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. EDAP TMS S.A.
  • 31.3. NeuWave Medical Inc.
  • 31.4. BVM Medical Limited
  • 31.5. Erbe Elektromedizin GmbH
  • 31.6. AtriCure Inc.
  • 31.7. Theraclion
  • 31.8. INTIO Inc.
  • 31.9. BIOTRONIK SE & Co. KG
  • 31.10. Olympus Corporation
  • 31.11. Stryker Corporation
  • 31.12. Merit Medical Systems Inc.
  • 31.13. Insightec Ltd.
  • 31.14. Terumo Corporation
  • 31.15. Smith & Nephew plc

32. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

34. Recent Developments In The Tumor Ablation Therapy Devices Market

35. Tumor Ablation Therapy Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Ablation Therapy Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Ablation Therapy Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Ablation Therapy Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer